Literature DB >> 886020

Alveolar rhabdomyosarcoma presenting as subacute intravascular coagulation.

A Eldor, E Naparstek, J H Boss, S Biran.   

Abstract

A patient with rhabdomyosarcoma is described in whom the presenting clinical and laboratory features were those of disseminated intravascular coagulation. The patient's rapid downhill course was primarily expressed by haemorrhagic tendency. An alveolar rhabdomyosarcoma, affecting many organs, including vascular and cardiac lumina, was found at necropsy and was considered to be the cause of the consumption coagulopathy.

Entities:  

Mesh:

Year:  1977        PMID: 886020      PMCID: PMC476509          DOI: 10.1136/jcp.30.7.661

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.

Authors:  R R PROCTOR; S I RAPAPORT
Journal:  Am J Clin Pathol       Date:  1961-09       Impact factor: 2.493

2.  Rhabdomyosarcoma: a clinicopathological study and classification of 39 cases.

Authors:  R C HORN; H T ENTERLINE
Journal:  Cancer       Date:  1958 Jan-Feb       Impact factor: 6.860

3.  Methods for the evaluation of human fibrinolysis; studies with two combined technics.

Authors:  K N VON KAULLA; R L SCHULTZ
Journal:  Am J Clin Pathol       Date:  1958-02       Impact factor: 2.493

4.  Rhabdomyosarcoma with fatal hemorrhage from intestinal metastases; case report with autopsy.

Authors:  F C LECHNER; T J MORAN
Journal:  Am J Clin Pathol       Date:  1952-05       Impact factor: 2.493

5.  A new method for the determination of fibrinogen in small samples of plasma.

Authors:  O D RATNOFF; C MENZIE
Journal:  J Lab Clin Med       Date:  1951-02

6.  Blood coagulation studies in patients with cancer.

Authors:  N C Sun; E J Bowie; F J Kazmier; L R Elveback; C A Owen
Journal:  Mayo Clin Proc       Date:  1974-09       Impact factor: 7.616

7.  Disseminated intravascular coagulation in cancer patients: supportive evidence.

Authors:  S D Peck; C W Reiquam
Journal:  Cancer       Date:  1973-05       Impact factor: 6.860

8.  Alveolar rhabdomyosarcoma. An analysis of 110 cases.

Authors:  F M Enzinger; M Shiraki
Journal:  Cancer       Date:  1969-07       Impact factor: 6.860

9.  The defibrination syndrome: clinical features and laboratory diagnosis.

Authors:  C Merskey; A J Johnson; G J Kleiner; H Wohl
Journal:  Br J Haematol       Date:  1967-07       Impact factor: 6.998

10.  Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment.

Authors:  C Merskey; G J Kleiner; A J Johnson
Journal:  Blood       Date:  1966-07       Impact factor: 22.113

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.